Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver.
暂无分享,去创建一个
B. Grimes | T. Meyerrose | S J Szilvassy | S. Szilvassy | T E Meyerrose | P L Ragland | B Grimes | P. Ragland
[1] E. Shpall,et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. , 2000, Blood.
[2] C. Verfaillie,et al. Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: implications for anatomical localization and developmental stage specific regulation of hematopoiesis. , 1999, Experimental hematology.
[3] D. Clapp,et al. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. , 1998, Blood.
[4] I. Weissman,et al. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells , 1993, The Journal of cell biology.
[5] D. Boggs,et al. The total marrow mass of the mouse: A simplified method of measurement , 1984, American journal of hematology.
[6] J. Goldman. Peripheral blood stem cells for allografting [editorial] [see comments] , 1995 .
[7] R. Hoffman,et al. An in vivo competitive repopulation assay for various sources of human hematopoietic stem cells. , 2000, Blood.
[8] D. Slamon,et al. Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer. , 2000, Blood.
[9] L. To,et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. , 1992, Bone marrow transplantation.
[10] C. Figdor,et al. Murine hematopoietic progenitor cells with colony-forming or radioprotective capacity lack expression of the beta 2-integrin LFA-1. , 1999, Blood.
[11] A. Tsukamoto,et al. The unexpected G0/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood. , 1997, Blood.
[12] R. Willemze,et al. The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Wagner,et al. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. , 1997, Blood.
[14] R. Champlin,et al. Peripheral Blood Progenitor Cell Transplantation: A Replacement for Marrow Auto‐ or Allografts , 1996, Stem cells.
[15] W. Nibley,et al. Primitive stem cells alone mediate rapid marrow recovery and multilineage engraftment after transplantation , 1998, Bone Marrow Transplantation.
[16] J. Goldman. Peripheral blood stem cells for allografting. , 1995, Blood.
[17] R. Schots,et al. Circulating CD34+ cells in cord blood and mobilized blood have a different profile of adhesion molecules than bone marrow CD34+ cells , 1998, European journal of haematology.
[18] P. Lansdorp,et al. A comparison of long-term repopulating hematopoietic stem cells in fetal liver and adult bone marrow from the mouse. , 1996, Experimental hematology.
[19] D. Thomas,et al. Preferential adhesion of fetal liver derived primitive haemopoietic progenitor cells to bone marrow stroma , 1997, British journal of haematology.
[20] I. Lemischka,et al. Relative to adult marrow, fetal liver repopulates nearly five times more effectively long-term than short-term. , 1997, Experimental hematology.
[21] M. Yoder,et al. Homing and engraftment potential of Sca-1(+)lin(-) cells fractionated on the basis of adhesion molecule expression and position in cell cycle. , 2000, Blood.
[22] C. Craddock,et al. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[23] G. Molineux,et al. Megakaryocyte growth and development factor accelerates platelet recovery in peripheral blood progenitor cell transplant recipients. , 1996, Blood.
[24] M. Collector,et al. Hematopoietic stem cell tracking in vivo: a comparison of short-term and long-term repopulating cells. , 1999, Blood.
[25] T. Papayannopoulou,et al. Homing of human cells in the fetal sheep model: modulation by antibodies activating or inhibiting very late activation antigen-4-dependent function. , 1999, Blood.
[26] G. Molineux,et al. Flt-3 ligand synergizes with granulocyte colony-stimulating factor to increase neutrophil numbers and to mobilize peripheral blood stem cells with long-term repopulating potential. , 1997, Blood.
[27] R. Hoffman,et al. Partially differentiated ex vivo expanded cells accelerate hematologic recovery in myeloablated mice transplanted with highly enriched long-term repopulating stem cells. , 1996, Blood.
[28] P. Lansdorp,et al. Ontogeny-related changes in proliferative potential of human hematopoietic cells , 1993, The Journal of experimental medicine.
[29] B. Grimes,et al. Organ-selective homing defines engraftment kinetics of murine hematopoietic stem cells and is compromised by Ex vivo expansion. , 1999, Blood.
[30] I. Weissman,et al. The purification and characterization of fetal liver hematopoietic stem cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Jackson,et al. Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation. , 1998, Experimental hematology.
[32] C. Eaves,et al. Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[33] J F Keij,et al. Homing of fluorescently labeled murine hematopoietic stem cells. , 1996, Experimental hematology.
[34] L. To,et al. Defining a therapeutic dose of peripheral blood stem cells. , 1992, Journal of hematotherapy.
[35] J. Wuu,et al. The Fluctuating Phenotype of the Lymphohematopoietic Stem Cell with Cell Cycle Transit , 1998, The Journal of experimental medicine.
[36] K. Miyake,et al. Activation of CD44 induces ICAM‐1/LFA‐1‐independent, Ca2+, Mg2+, —independent adhesion pathway in lymphocyte‐endothelial cell interaction , 1993, European journal of immunology.
[37] K. Miyake,et al. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long- term bone marrow cultures , 1990, The Journal of experimental medicine.
[38] M. Moore,et al. Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential. , 1993, Blood.
[39] J. Mary,et al. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. , 1998, Blood.
[40] B. Grimes,et al. Effects of cell cycle activation on the short-term engraftment properties of ex vivo expanded murine hematopoietic cells. , 2000, Blood.
[41] C. Craddock,et al. VLA4/VCAM‐1接着経路が骨髄とひ臓の間で移植したマウス造血幹細胞の対照的な定着機構を決定する , 1995 .